Annual ROA
-46.50%
-31.26%-205.12%
December 31, 2024
Summary
- As of February 26, 2025, TVTX annual return on assets is -46.50%, with the most recent change of -31.26% (-205.12%) on December 31, 2024.
- During the last 3 years, TVTX annual ROA has fallen by -20.48% (-78.71%).
- TVTX annual ROA is now -228.45% below its all-time high of 36.20%, reached on December 31, 2015.
Performance
TVTX ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-51.83%
+0.77%+1.46%
December 1, 2024
Summary
- As of February 26, 2025, TVTX quarterly return on assets is -51.83%, with the most recent change of +0.77% (+1.46%) on December 1, 2024.
- Over the past year, TVTX quarterly ROA has dropped by -37.32% (-257.20%).
- TVTX quarterly ROA is now -276.89% below its all-time high of 29.30%, reached on December 31, 2015.
Performance
TVTX Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
TVTX ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -205.1% | -257.2% |
| 3 y3 years | -78.7% | -257.2% |
| 5 y5 years | -108.6% | -257.2% |
TVTX ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -205.1% | at low | -349.5% | +1.5% |
| 5 y | 5-year | -205.1% | at low | -349.5% | +1.5% |
| alltime | all time | -228.4% | +96.3% | -276.9% | +91.0% |
Travere Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -46.50%(+205.1%) | - |
| Dec 2024 | - | -51.83%(-1.5%) |
| Sep 2024 | - | -52.60%(+157.6%) |
| Jun 2024 | - | -20.42%(-2.9%) |
| Mar 2024 | - | -21.04%(+45.0%) |
| Dec 2023 | -15.24%(-60.3%) | -14.51%(+25.8%) |
| Sep 2023 | - | -11.53%(-72.1%) |
| Jun 2023 | - | -41.29%(+9.1%) |
| Mar 2023 | - | -37.86%(+2.9%) |
| Dec 2022 | -38.43%(+47.7%) | -36.80%(+8.2%) |
| Sep 2022 | - | -34.00%(+15.4%) |
| Jun 2022 | - | -29.47%(+13.4%) |
| Mar 2022 | - | -25.98%(+5.9%) |
| Dec 2021 | -26.02%(-6.9%) | -24.54%(-29.6%) |
| Sep 2021 | - | -34.88%(+2.7%) |
| Jun 2021 | - | -33.97%(+0.5%) |
| Mar 2021 | - | -33.80%(+25.9%) |
| Dec 2020 | -27.95%(+25.4%) | -26.84%(+117.5%) |
| Sep 2020 | - | -12.34%(-16.3%) |
| Jun 2020 | - | -14.75%(-12.4%) |
| Mar 2020 | - | -16.84%(-25.4%) |
| Dec 2019 | -22.29%(+33.5%) | -22.58%(+22.5%) |
| Sep 2019 | - | -18.43%(-15.9%) |
| Jun 2019 | - | -21.92%(+8.0%) |
| Mar 2019 | - | -20.30%(+16.1%) |
| Dec 2018 | -16.70%(+46.2%) | -17.48%(-14.8%) |
| Sep 2018 | - | -20.52%(+37.0%) |
| Jun 2018 | - | -14.98%(+14.4%) |
| Mar 2018 | - | -13.09%(+13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | -11.42%(+23.7%) | -11.56%(+18.3%) |
| Sep 2017 | - | -9.77%(-27.2%) |
| Jun 2017 | - | -13.42%(-0.2%) |
| Mar 2017 | - | -13.45%(+46.7%) |
| Dec 2016 | -9.23%(-125.5%) | -9.17%(+14.1%) |
| Sep 2016 | - | -8.04%(-139.7%) |
| Jun 2016 | - | 20.26%(+8.2%) |
| Mar 2016 | - | 18.72%(-36.1%) |
| Dec 2015 | 36.20%(-144.2%) | 29.30%(+5.6%) |
| Sep 2015 | - | 27.74%(-315.7%) |
| Jun 2015 | - | -12.86%(-647.2%) |
| Mar 2015 | - | 2.35%(-102.8%) |
| Dec 2014 | -81.89%(-51.5%) | -83.57%(-9.3%) |
| Sep 2014 | - | -92.16%(-24.4%) |
| Jun 2014 | - | -121.83%(-60.0%) |
| Mar 2014 | - | -304.85%(+8.5%) |
| Dec 2013 | -168.91%(-86.7%) | -280.89%(-2.2%) |
| Sep 2013 | - | -287.24%(-44.8%) |
| Jun 2013 | - | -520.22%(+32.3%) |
| Mar 2013 | - | -393.32%(+2.3%) |
| Dec 2012 | -1268.93%(+234.4%) | - |
| Nov 2012 | - | -384.62%(+1.4%) |
| Aug 2012 | - | -379.49%(0.0%) |
| May 2012 | - | -379.49%(0.0%) |
| Feb 2012 | - | -379.49%(+2.2%) |
| Feb 2012 | -379.49%(-34.0%) | - |
| Nov 2011 | - | -371.19%(-12.7%) |
| Aug 2011 | - | -425.32%(-14.5%) |
| May 2011 | - | -497.50%(-13.5%) |
| Feb 2011 | -575.00% | -575.00% |
FAQ
- What is Travere Therapeutics annual return on assets?
- What is the all time high annual ROA for Travere Therapeutics?
- What is Travere Therapeutics annual ROA year-on-year change?
- What is Travere Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Travere Therapeutics?
- What is Travere Therapeutics quarterly ROA year-on-year change?
What is Travere Therapeutics annual return on assets?
The current annual ROA of TVTX is -46.50%
What is the all time high annual ROA for Travere Therapeutics?
Travere Therapeutics all-time high annual return on assets is 36.20%
What is Travere Therapeutics annual ROA year-on-year change?
Over the past year, TVTX annual return on assets has changed by -31.26% (-205.12%)
What is Travere Therapeutics quarterly return on assets?
The current quarterly ROA of TVTX is -51.83%
What is the all time high quarterly ROA for Travere Therapeutics?
Travere Therapeutics all-time high quarterly return on assets is 29.30%
What is Travere Therapeutics quarterly ROA year-on-year change?
Over the past year, TVTX quarterly return on assets has changed by -37.32% (-257.20%)